Genetic Factors Associated with Risk and Disability Progression of Multiple Sclerosis in Slovak Population

1. Nischwitz S, Muller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Lett. 2011; 585 (23): 3789-97.10.1016/j.febslet.2011.03.03721439284Search in Google Scholar

2. Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. The International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476 (7359): 214-9.10.1038/nature10251318253121833088Search in Google Scholar

3. Zhang Q, Lin CY, Dong Q, Wang J, Wang W. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev. 2011; 10 (8): 474-81.10.1016/j.autrev.2011.03.00321440682Search in Google Scholar

4. Faitar SL, Sossey-Alaoui K, Ranalli TA, Cowell JK. EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis. Exp Cell Res. 2006;312 (12): 2325-35.10.1016/j.yexcr.2006.03.03216764853Search in Google Scholar

5. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, et al. Multiple sclerosis susceptibilitygenes: associations with relapse severity and recovery. PLoS One. 2013; 8 (10): e75416. 10.1371/journal.pone.0075416379399124130709Search in Google Scholar

6. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S et al. Multiple sclerosis severityscore: using disability and disease duration to rate disease severity. Neurology. 2005; 64 (7): 1144-51. 10.1212/01.WNL.0000156155.19270.F815824338Search in Google Scholar

7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33 (11) :1444-52.10.1212/WNL.33.11.14446685237Search in Google Scholar

8. Čierny D, Hanyšova S, Michalik J, Kantorova E, Kurča E, Škereňova M, Lehotsky J. Genetic variants in interleukin 7 receptor chain (IL-7Ra) are associated with multiple sclerosis risk and disability progression in Central European Slovak population. J Neuroimmunol. 2015; 282: 80-4.10.1016/j.jneuroim.2015.03.01025903732Search in Google Scholar

9. Čierny D, Michalik J, Kurča E, Dobrota D, Lehotsky J. FokI vitamin D receptor gene polymorphism in association with multiple sclerosis risk and disability progression in Slovaks. Neurol Res. 2015; 37 (4): 301-8.10.1179/1743132814Y.000000045925376135Search in Google Scholar

10. Alexoudi A, Zachaki S, Stavropoulou C, Gavrili S, Spiliopoulou C, Papadodima S et al. Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis. Ann Clin Lab Sci. 2016; 46 (6): 586-591.Search in Google Scholar

11. Mann CL, Davies MB, Boggild MD, Alldersea J, Fryer AA, Jones PW et al. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology. 2000; 54(3): 552-7.10.1212/WNL.54.3.552Search in Google Scholar

12. Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A. The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis. J Neurol Sci. 2013; 334(1-2):6-9.10.1016/j.jns.2013.07.00123932298Search in Google Scholar

13. Stavropoulou C, Korakaki D, Rigana H, Voutsinas G, Polyzoi M, Georgakakos VN et al. Glutathione-Stransferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study. Eur J Neurol. 2007; 14(5): 572-4.10.1111/j.1468-1331.2006.01678.x17437619Search in Google Scholar

14. Bačić Baronica K, Mlinac K, Petlevski R, Ozretić D, Vladić A, Kalanj-Bognar S, Zuntar I. Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway. Acta Neurobiol Exp (Wars). 2014; 74(3): 257-65.Search in Google Scholar

15. Hafler DA et al., INTERNATIONAL MULTIPLE SCLEROSIS GENETICS CONSORTIUM 1. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007; 2007357 (9): 851-62.Search in Google Scholar

16. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, Van Duijn CM, Hintzen RQ. EVI5 is a risk gene for multiple sclerosis. Genes Immun. 2008; 9 (4): 334-7.10.1038/gene.2008.2218401352Search in Google Scholar

17. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010; 11 (4): 343-50.10.1038/gene.2009.81288021719865102Search in Google Scholar